Evidence map›Paper›PMID 37175849›Full record

ArticleInternational journal of molecular sciences2023

Polylevolysine and Fibronectin-Loaded Nano-Hydroxyapatite/PGLA/Dextran-Based Scaffolds for Improving Bone Regeneration: A Histomorphometric in Animal Study.

Elena Canciani, Paola Straticò, Vincenzo Varasano, Claudia Dellavia, Chiara Sciarrini, Lucio Petrizzi, Lia Rimondini, Elena M Varoni

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Diabetes and cancer: therapeutic implications.Cardio-oncology (London, England) · 2026
    Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Elena CancianiDepartment of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0002-6987-6794
Paola StraticòDepartment of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.ORCID 0000-0001-5482-2665
Vincenzo VarasanoDepartment of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.
Claudia DellaviaDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, 20142 Milan, Italy.ORCID 0000-0001-5145-3606
Chiara SciarriniDepartment of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.
Lucio PetrizziDepartment of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.ORCID 0000-0001-7830-7545
Lia RimondiniDepartment of Health Sciences, Università del Piemonte Orientale, 28100 Novara, Italy.ORCID 0000-0002-7785-2282
Elena M VaroniDepartment of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, 20142 Milan, Italy.ORCID 0000-0002-7287-2188
University of Teramo · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The regeneration of large bone defects is still demanding, requiring biocompatible scaffolds, with osteoconductive and osteoinductive properties. This study aimed to assess the pre-clinical efficacy of a nano-hydroxyapatite (nano-HA)/PGLA/dextran-based scaffold loaded with Polylevolysine (PLL) and fibronectin (FN), intended for bone regeneration of a critical-size tibial defect, using an ovine model. After physicochemical characterization, the scaffolds were implanted in vivo, producing two monocortical defects on both tibiae of ten adult sheep, randomly divided into two groups to be euthanized at three and six months after surgery. The proximal left and right defects were filled, respectively, with the test scaffold (nano-HA/PGLA/dextran-based scaffold loaded with PLL and FN) and the control scaffold (nano-HA/PGLA/dextran-based scaffold not loaded with PLL and FN); the distal defects were considered negative control sites, not receiving any scaffold. Histological and histomorphometric analyses were performed to quantify the bone ingrowth and residual material 3 and 6 months after surgery. In both scaffolds, the morphological analyses, at the SEM, revealed the presence of submicrometric crystals on the surfaces and within the scaffolds, while optical microscopy showed a macroscopic 3D porous architecture. XRD confirmed the presence of nano-HA with a high level of crystallinity degree. At the histological and histomorphometric evaluation, new bone formation and residual biomaterial were detectable inside the defects 3 months after intervention, without differences between the scaffolds. At 6 months, the regenerated bone was significantly higher in the defects filled with the test scaffold (loaded with PLL and FN) than in those filled with the control scaffold, while the residual material was higher in correspondence to the control scaffold. Nano-HA/PGLA/dextran-based scaffolds loaded with PLL and FN appear promising in promoting bone regeneration in critical-size defects, showing balanced regenerative and resorbable properties to support new bone deposition.

Indexed as

DurapatiteTissue ScaffoldsAnimalsAntimicrobial Cationic PeptidesBone RegenerationDextransFibronectinsOsteogenesisSheepAntimicrobial Cationic PeptidesDextransDurapatiteFibronectinspeptide-Gly-Leu-amidebone regenerationcritical-size bone defectfibronectinhydroxyapatitePolylevolysine

Identifiers

PMID37175849
PMCPMC10179305
OpenAlexW4368377262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.